At a glance
ClinicalIndex Comparison RecordN/ACompleted· 58 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cost-minimization Analysis of Xeloda® vs 5-fluorouracil-based Treatment for Gastric Cancer Patients in Hong Kong
In Brief
An observational study for Gastric Cancer. Completed, enrolled 58 participants across 1 site.
Detailed Summary
This is a retrospective cost-minimization analysis study to compare the costs of treatment with EOF vs EOX regimens in patients with gastric cancer (GC) in Hong Kong. Patient baseline characteristics and cost data will be extracted from records and compared.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesHong Kong
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionJul 2012
First PostedSep 2012
TodayJul 2026
First PostedSep 5, 2012
Enrollment StartOct 1, 2011
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.8 years ago